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Patient Compliance with Clinical Follow-up
After Total Joint Arthroplasty
By John C. Clohisy, MD, Ganesh V. Kamath, MD, Gregory D. Byrd, MD, Karen Steger-May, MA, and Rick W. Wright, MD
Investigation performed at the Department of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington
University School of Medicine, St. Louis, Missouri

Background: Periodic clinical and radiographic evaluation is commonly recommended by orthopaedic surgeons to monitor
patients following total joint arthroplasty, yet the compliance with and efficacy of patient follow-up protocols have not been well
defined. The purpose of this study was to evaluate patient compliance with early clinical follow-up after total hip arthroplasty or
total knee arthroplasty.
Methods: We performed a retrospective review of clinical follow-up compliance for 776 patients who had undergone a total
joint arthroplasty in the lower extremity. This cohort included 505 total hip arthroplasties (372 primary and 133 revision
procedures) and 271 total knee arthroplasties (195 primary and seventy-six revision procedures). The patients were given
one-time verbal instructions by the treating surgeon at the three-month postoperative visit to return for the one-year follow-up
evaluation. At the one-year follow-up evaluation, those who returned were once again verbally instructed to return a year later.
Demographic factors, functional hip and knee scores, and follow-up compliance at one and two years after surgery were
assessed.
Results: Patient compliance with clinical follow-up after all arthroplasties was 61% at one year and 36% at two years. With
use of a multivariate model for patients who had total hip arthroplasty, the analyses showed that a revision hip procedure (p =
0.006), younger patient age (p = 0.04), and a higher preoperative Harris hip score for gait (p = 0.04) were associated with
follow-up compliance at two years. Of the factors analyzed for patients who had total knee arthroplasty, only nonwhite race
(p = 0.03) was found to be a positive predictor of follow-up compliance at the two-year follow-up interval.
Conclusions: Patient compliance with clinical follow-up after total joint arthroplasty in response to a verbal request made by
the surgeon once at three months and once at one year postoperatively was poor in this series. These data indicate that this
method (one-time verbal instruction) is insufficient to ensure compliance for follow-up after total joint arthroplasty.

M

ore than 500,000 total hip and knee arthroplasties
were performed in the United States in the year 2000,
and the rate of total joint replacement is projected to
increase 5% annually1,2. On the basis of data collected through
the United States Census Bureau, Kurtz et al. estimated that the
demand for total hip arthroplasty will increase to 572,000 procedures annually by the year 2030, with the demand for primary
total knee arthroplasty reaching approximately 3.5 million3. With
an increasingly aging population, primary total joint arthroplasty
of the hip and knee will become even more common and consequently the follow-up of these patients will be substantial.

The longevity of total joint arthroplasty can be limited by
problems such as wear-debris-induced osteolysis and aseptic
loosening4-7. Unfortunately, delayed diagnosis of these problems can result in the need for complex and costly revision
surgery8,9. Thus, periodic postoperative clinical and radiographic analysis to provide early detection of bearing surface
wear, osteolysis, and implant loosening seems prudent. Followup visits for arthroplasty surveillance have traditionally
been performed by the operating surgeon in the outpatient
setting. To our knowledge, however, the extent to which patients comply with this recommendation and the efficacy of
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this type of patient surveillance have not been rigorously
analyzed.
The purpose of this study was to determine the compliance with clinical follow-up in a consecutive series of patients who had hip or knee arthroplasty at our institution. In
addition, we analyzed the positive and negative predictors for
clinical follow-up compliance.
Materials and Methods
total of 776 patients underwent total knee or total hip
arthroplasty performed by one surgeon (J.C.C.) between
September 1998 and January 2003. This cohort included 505
total hip arthroplasties (372 primary and 133 revision procedures) and 271 total knee arthroplasties (195 primary and
seventy-six revision procedures). All patients consented to an
institutional review board-approved protocol for prospective
data collection. In the primary total hip arthroplasty group,
there was a subgroup of twenty-nine patients who were part of
a prospective, randomized clinical trial of a specific arthroplasty
implant and served as a comparison group in this study. These
patients were contacted by telephone to schedule their annual
follow-up appointments and to remind them to attend. If these
patients did not attend a scheduled visit, they were contacted
by telephone to reschedule an appointment, and they were
repeatedly contacted by telephone until they attended the annual visit. If a patient declined further follow-up evaluation, no
more telephone contact was performed.
The remaining 747 patients constituted the study group,
and they were analyzed collectively and by the type of procedure they underwent. Twelve patients (seven who had a primary total hip arthroplasty; three, a revision total hip arthroplasty;
one, a primary total knee arthroplasty; and one, a revision total
knee arthroplasty) died prior to one year of follow-up and were
excluded from all analyses, leaving 735 patients for inclusion in
the study group and available for the one-year follow-up visit. An
additional five patients (one who had a primary total hip arthroplasty; three, a revision total hip arthroplasty; and one, a
revision total knee arthroplasty) died prior to the two-year
follow-up evaluation, leaving 730 patients available for the
two-year analysis. At the time of hospital discharge, all patients
in the study group were given appointments to be seen for
follow-up at six weeks and three months postoperatively. At
the three-month visit, they were given verbal instructions by
the primary surgeon to return at one year postoperatively. At the
one-year visit, the patients were again verbally instructed by the
surgeon to return in one year for a two-year postoperative visit.
For annual appointments, the patient was given the month and
the year of the next appointment (verbally and in written form
on the billing sheet). At checkout, the patient was given two
options by the receptionist: (1) immediately schedule the future
appointment through the receptionist or (2) contact the office by
telephone at a later date to schedule the routine annual followup. We did not perform follow-up telephone calls or mail notifications to remind these patients of their appointments.
We retrospectively queried our registry to determine the
follow-up compliance of patients who had undergone either total
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hip arthroplasty or total knee arthroplasty. The 735 patients were
subdivided into four groups: (1) primary total hip arthroplasty,
(2) revision total hip arthroplasty, (3) primary total knee arthroplasty, and (4) revision total knee arthroplasty.
Data for all patient visits were recorded prospectively.
For patients who received bilateral joint arthroplasty, only data
from the first procedure were utilized. If both procedures occurred on the same day, only one set of preoperative joint
scores was utilized. If a patient received a primary hip or knee
arthroplasty and subsequently required a revision procedure,
they were excluded from the hip and knee revision data set
analyses to guarantee that no single patient was counted twice
in this study. The Social Security numbers for all patients
analyzed were cross-referenced with the Social Security Death
Index to exclude any patients from the study who had died
within the two-year follow-up period.
The preoperative information included first and last name,
Social Security number, age, date of surgery, date of follow-up
appointments, procedure performed (arthroplasty type), preoperative diagnosis, surgeon, race, sex, history of joint infection,
height, weight (both body mass index as a continuous variable, and
overweight status [body mass index of >25] as a dichotomous
variable), proximity to the medical center, Harris hip scores10 (pain,
gait, function, activity, and total score for the evaluated hip) for the
patients receiving a hip arthroplasty, and Knee Society function
and clinical scores11 for the patients receiving a knee arthroplasty.
Because of its skewed and abnormal distribution, proximity to the
medical center was dichotomized according to the distribution of
distances the patients lived from the medical center. Proximity was
categorized on the basis of the 75th percentile distance from the
medical center of fifty miles. This categorization allows comparison between patients who lived within fifty miles of the medical
center and patients who lived more than fifty miles away. Patient
compliance with follow-up was the primary outcome variable
analyzed. A ninety-day window of eligibility was chosen for each
annual follow-up visit. For example, a patient could successfully
return for the one-year follow-up visit as long as he or she returned to the office within the period from ninety days before to
ninety days after the one-year postoperative date.
All 735 patients were analyzed collectively, and each arthroplasty type was also analyzed separately (hip arthroplasty
and knee arthroplasty) to assess the association of procedurespecific measures with compliance. The data on the return of
patients for one-year and two-year follow-up were analyzed
separately, creating a total of six individual analyses.
Demographic and clinical variables for patients who did
and did not return for follow-up were compared with use of
logistic regression. Variables that were significant (p £ 0.05)
in univariate logistic regression analyses were analyzed in a
multivariate logistic regression analysis predicting compliance.
Adjusted odds ratios and corresponding 95% confidence intervals are reported for variables in the multivariate model,
adjusted for all other variables in the model. For categorical
predictors, the reference category for the adjusted odds ratio is
indicated with an adjusted odds ratio of 1.0. For continuous
predictors and unless otherwise noted, adjusted odds ratios
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TABLE I Summary of Total Hip Arthroplasty and Total Knee Arthroplasty Follow-up Compliance
Total Hip Arthroplasty

Total Knee Arthroplasty

Primary
(N = 336)

Revision
(N = 130)

All
(N = 466)

Primary
(N = 194)

Female sex*

195 (58)

80 (62)

275 (59)

140 (72)

White race*

254 (76)

111 (85)

365 (78)

Age† (yr)

57 ± 17

64 ± 15

59 ± 17

Variable

Body mass index†

(kg/m2)

Harris hip scores†
Pain
Gait
Activity
Function (gait and activity)
Total
Knee Society scores‡
Function
Knee score
Proximity to medical center*
£50 miles
>50 miles

29.1 ± 7
12.6
14.7
8.0
22.7
43.2

±
±
±
±
±

6
9
3
10
15

NA

13.9
10.6
7.0
17.6
40.1

±
±
±
±
±

9
9
3
11
19

NA

28.5 ± 6
13.0
13.6
7.7
21.3
42.4

±
±
±
±
±

All
(N = 269)

42 (56)

182 (68)

132 (68)

63 (84)

195 (72)

67 ± 12

67 ± 12

67 ± 12

31.7 ± 8

31.5 ± 7

31.6 ± 8

NA

NA

NA

44.4 ± 16
29.1 ± 13

46.3 ± 22
37.7 ± 18

44.9 ± 18
31.4 ± 15

152 (78)
42 (22)

56 (75)
19 (25)

208 (77)
61 (23)

7
9
3
11
16

NA

87 (67)
43 (33)

333 (71)
133 (29)

3 (2)

4 (1)

335 (99)

127 (98)

462 (99)

194 (100)

74 (99)

268 (99)

Attended 1-yr follow-up visit*

201 (60)

76 (58)

277 (59)

129 (66)

40 (53)

169 (63)

Attended 2-yr follow-up visit*§

107 (32)

54 (43)

161 (35)

79 (41)

22 (30)

101 (38)

Death*
Patients who died between
1 and 2 yr of follow-up
Patients who survived at
2 yr postop.

246 (73)
90 (27)

27.2 ± 6

Revision
(N = 75)

1 (0.3)

0

1 (1)

1 (0.4)

*The values are given as the number of patients, with the percentage in parentheses. †The values are given as the mean and the standard
deviation. According to the Harris hip-scoring system, pain was rated on a scale of 0 to 44 points; gait, from 0 to 33 points; activity, from 0 to 14
points; and function (which included gait and activity), from 0 to 47 points. The remaining 9 points are allocated to range of motion (5 points) and
absence of deformity (4 points), which were not included in this analysis. ‡The values are given as the mean and the standard deviation. The
function score ranges from 0 to 100 points, and the knee score ranges from 0 to 50 points. §The data are reported after excluding patients who
died between the one and two-year follow-up visit. NA = not applicable.

reflect the increase in the odds of returning for follow-up per a
one-unit increase in the variable. Adjusted odds ratios for age
are expressed in units of ten years. Data are reported as the
mean and the standard deviation or as the number of patients
(and the percentage of the group).
Results
f the study cohort of 735 patients, 466 patients were treated
with a total hip arthroplasty (336 primary and 130 revision
procedures), and 269 patients with a total knee arthroplasty (194
primary and seventy-five revision procedures). Follow-up compliance data according to procedure for all patients managed with
total hip or total knee arthroplasty are presented in Table I.

O

All Arthroplasty Procedures (Table I)
Clinical follow-up compliance for all patients combined was
61% (446 of 735 patients) at the one-year visit and 36% (262 of

730 patients) at the two-year follow-up visit. For the one-year
follow-up evaluation, we found that a lower body mass index
was associated positively with compliance. The mean body
mass index of patients returning for follow-up was 29.2 ± 7. In
comparison, the mean body mass index for patients who did
not return was 30.4 ± 7. This difference was significant (p =
0.03). In contrast to this finding, however, the dichotomous
overweight variable was not found to have a significant association with follow-up. Patients who lived within fifty miles of our
center were significantly more likely to return for follow-up (p =
0.005). However, at the two-year follow-up, none of the potential predictors we analyzed were significantly associated with
compliance (see Appendix).
The comparison group of twenty-nine patients who
were specifically contacted to secure follow-up appointments
had a compliance rate of 97% (twenty-eight patients) at both
one and two years, which was significantly better than the rate
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TABLE II Variables Associated with Patient Compliance with Follow-up at Two Years After Total Hip Arthroplasty
Multivariate Logistic
Regression Results

Attended Two-Year
Follow-up Visit
Variable

No
(N = 301)

Yes
(N = 161)

Revision or primary
procedure†
Revision
Primary

73 (24)
228 (76)

54 (34)
107 (66)

Sex†
Male
Female

128 (43)
173 (57)

63 (39)
98 (61)

Race†
Nonwhite
White

70 (23)
228 (77)

26 (16)
134 (84)

Overweight†
No
Yes

85 (29)
207 (71)

52 (34)
103 (66)

Age‡ (yr)
Body mass index‡
(kg/m2)
Proximity to medical
center†
£50 miles
>50 miles
Harris hip score‡
Pain
Gait
Activity
Function (gait and
activity)
Total

Univariate Logistic
Regression Results
(P Value)

P
Value

Adjusted Odds Ratio
(95% Confidence
Interval)*

0.03
0.006

1.00
0.52 (0.33, 0.83)

0.04

0.88 (0.78, 0.99)

0.79
0.04

1.00 (0.97, 1.04)
1.03 (1.00, 1.06)

0.48

0.07

0.33

60 ± 17
28.8 ± 6

56 ± 17
28.1 ± 6

0.03
0.26
0.67

213 (71)
88 (29)
12.6
12.9
7.6
20.5

±
±
±
±

7
9
3
11

41.0 ± 16

117 (73)
44 (27)
±8
±9
±3
± 11

0.05
0.01
0.12
0.01

45.0 ± 16

0.01

14.0
15.1
8.0
23.2

*Unless otherwise noted, adjusted odds ratios reflect the increased odds of attending the two-year follow-up visit for a one-unit increase in the
variable, after adjusting for all other variables in the model. For categorical variables, the first category listed is the reference category for the
adjusted odds ratio. The adjusted odds ratios for age are expressed in units of ten years. †The values are given as the number of patients, with the
percentage in parentheses. Data on weight were unavailable for fifteen patients, and data on race were unavailable for four patients. ‡The values
are given as the mean and the standard deviation.

of 61% at one year and 36% at two years in the study group
(p < 0.0001).
Hip Arthroplasty (Tables I and II)
Of the 466 patients who received a total hip arthroplasty,
277 (59%) returned for the recommended one-year followup, and 161 (35%) of the 462 who were still alive returned for
the two-year evaluation (Table I). After multivariate regression analysis of the one-year follow-up information (data
not shown), positive predictors for returning for follow-up
were found to be white race (p = 0.009), the preoperative
Harris hip score for gait (p = 0.04), and a proximity to the
medical center of less than fifty miles (p = 0.006). A com-

parison of follow-up compliance after revision and primary arthroplasty procedures did not reveal any significant
difference.
Analysis of the data at the two-year follow-up visit
showed that the type of arthroplasty (revision or primary) was
a significant independent predictor of follow-up (p = 0.006,
Table II), as patients who had a revision were more likely to
return. Younger age (p = 0.04) and a better preoperative Harris
hip score for gait (p = 0.04) were also found to be positive
predictors of patient compliance with follow-up at two years,
implying that patients who were younger and more mobile preoperatively were more likely to return for follow-up appointments. In the comparison group of twenty-nine patients, the rate
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TABLE III Variables Associated with Patient Compliance with Follow-up at Two Years After Total Knee Arthroplasty
Univariate Logistic
Regression Results

Attended Two-Year
Follow-up Visit
No
(N = 167)

Yes
(N = 101)

Revision or primary†
Revision
Primary

52 (31)
115 (69)

22 (22)
79 (78)

Sex†
Male
Female

53 (32)
114 (68)

34 (34)
67 (66)

Race†
Nonwhite
White

38 (23)
129 (77)

35 (35)
66 (65)

Overweight†
No
Yes

28 (17)
137 (83)

14 (14)
86 (86)

Variable

P
Value
0.10

0.74

0.03
1.00
0.56 (0.32, 0.96)
0.52

66 ± 12

Age‡ (yr)
(kg/m2)

67 ± 12

0.58

32.0 ± 9

30.9 ± 6

Proximity to medical center†
£50 miles
>50 miles

123 (74)
44 (26)

84 (83)
17 (17)

Knee Society function score‡

44.4 ± 18

45.7 ± 18

0.54

Knee Society total score‡

31.2 ± 14

31.4 ± 16

0.93

Body mass index‡

Unadjusted Odds Ratio
(95% Confidence
Interval)*

0.24
0.07

*Unadjusted odds ratios reflect the increased odds of attending the two-year follow-up visit for a one-unit increase in the variable. The first
category listed is the reference category for the odds ratio. †The values are given as the number of patients, with the percentage in parentheses.
Data on weight were unavailable for three patients. ‡The values are given as the mean and the standard deviation.

of follow-up compliance for the two-year follow-up appointment was 97% (twenty-eight patients), which was significantly
better than the rate of 35% (161) of 462 patients in the study
group (p < 0.0001).
Knee Arthroplasty (Tables I and III)
The overall rate of follow-up compliance after total knee arthroplasty was 63% (169) of 269 patients at the one-year visit
and 38% (101) of the 268 patients who were still alive at the time
of the two-year follow-up (Table I). After multivariate analysis
of the one-year data (not shown), the only factor that was
found to be positively associated with compliance was female
sex (p = 0.03). Being overweight (a body mass index of >25)
was identified as a negative predictor of follow-up compliance
(p = 0.04). The Knee Society score and type of procedure
(primary or revision) did not appear to significantly impact
follow-up compliance.
At the two-year interval (Table III), nonwhite race was
a positive predictor of follow-up compliance (p = 0.03). The
other variables, including revision or primary procedure,
sex, and weight, did not appear to alter the likelihood for
follow-up at the two-year interval. Only univariate analysis

was performed for the two-year data because there was only
one predictor and/or factor for compliance (nonwhite race).
Discussion
s the demand for hip and knee arthroplasties continues to
increase with time, there is a corresponding need to define
practical methods of postoperative surveillance. The costeffectiveness of surveillance protocols must also be analyzed and
justified. Recommendations for patient follow-up should aim,
at least in part, to identify problems in a timely way so that, if
necessary, a less complicated revision procedure may be performed. The reasons for revision hip arthroplasty have recently
been analyzed. Specifically, Clohisy et al.12 found that, of 439
revision hip procedures performed, 55% were performed for
aseptic loosening and an additional 13% were performed for
osteolysis around well-fixed components. Paprosky et al.13 also
reported on failure modes requiring revision hip arthroplasty.
They noted that, of the 270 consecutive revisions on the acetabular side, 71% were performed for osteolysis or loosening of
the cup. Malchau14 examined the Swedish arthroplasty registry
and reported that 74% of the 8878 first-time revisions were
performed for aseptic loosening.
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Maloney et al.15 reported that acetabular osteolysis was
detected in twenty-five (2.3%) of 1081 hips at the five to tenyear follow-up evaluation. For the 168 patients followed for a
minimum of ten years, 12.2% had pelvic osteolysis. Similarly,
O’Rourke et al.16 reported that seventeen (16%) of 105 modular total knees (all with radiographic follow-up) had osteolysis of five to eight years after surgery. Thus, with conventional
hip and knee implants, the five to ten-year postoperative period is a timely interval for surveillance. This calls into question the clinical value and cost-effectiveness of early (one to
five-year) follow-up visits. Perhaps the major benefit of early
follow-up is to have the patient establish a pattern of compliance with follow-up.
Changing patient demographics may also impact surveillance protocols after arthroplasty. For example, the number
of young active patients undergoing hip and knee arthroplasty
procedures continues to increase. Combined with an emphasis
on maintaining an active lifestyle, these factors increase the
number of patients at risk for wear-induced osteolysis. Crowther
and Lachiewicz17 examined fifty-six young patients who had a
hip arthroplasty, with young defined as an age of less than fifty
years, and found that the incidence of pelvic osteolysis was 23%
at a minimum of nine years of follow-up. They also observed
a high rate of polyethylene wear of 0.15 mm/yr. Additionally,
Maloney et al.15 found a similar rate of osteolysis after hip arthroplasty in patients younger than fifty years (22%; fifteen hips),
a much lower rate of osteolysis in patients older than fifty years
(7.8%; eight hips), and no osteolysis in those patients older than
seventy years. Thus, younger patients undergoing hip arthroplasty are at an increased risk of wear and lysis problems. We
recommend that young patients (less than fifty years old) be
monitored at five and ten years after arthroplasty. If wear and
lysis problems are identified, the patient should be monitored
more frequently.
Currently, there are no definitive recommendations for
the frequency of patient follow-up after total joint arthroplasty.
In a recent survey of active members of the American Association of Hip and Knee Surgeons conducted by Teeny et al.1,
there was great discrepancy among surgeons regarding their
recommendations for follow-up after total joint arthroplasty.
In the one to five-year follow-up period after total hip arthroplasty,
46% of the surgeons thought that annual appointments were
necessary and 40% believed that biennial visits were sufficient.
There were similar results regarding follow-up of total knee
arthroplasty, with 45% of the surgeons advocating annual
follow-up visits and 40% preferring biennial follow-up appointments. Given the time range for the development of problems related to wear and lysis12,15, and the known increased risk in
young active patients, we suggest that an ideal follow-up protocol
should incorporate these factors.
Regardless of frequency, the compliance in almost all
studies has been reported to be extremely low. Joshi et al.18
conducted a study designed to assess outcome in patients lost
to follow-up. They attempted to contact all patients who had a
total knee arthroplasty performed between 1976 and 1988 at
their institution for a minimum ten-year follow-up evaluation.
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Despite surgeon-initiated contact efforts, 123 (23%) of 563 patients did not comply; however, with the use of private detectives
and research assistants, their group was able to obtain postoperative functional scores and clinical outcomes for all patients.
Many reasons are cited for high rates of patients lost to
follow-up, including a change of residence, difficulty with
traveling, scheduling conflicts, and doctor’s office delays18,19.
Sethuraman et al.19 questioned 100 asymptomatic patients at
routine follow-up evaluations after total knee arthroplasty and
found that forty-five patients would have preferred not to return to the doctor’s office because of the inconvenience and a
perceived lack of benefit. Moreover, they found that those
patients would be content to mail questionnaires back to the
physician’s office regarding functional status along with routine
radiographs. No patient felt that quality of care would be compromised with such a treatment algorithm.
Despite demonstrating a clear deficiency in patient
compliance with our protocol of short-term follow-up, our
study has certain limitations that must be acknowledged. First,
registry data from only one surgeon’s practice in a limited
geographic area were included. The practice analyzed in this
study drew patients from a large demographic area, including
both urban and rural populations in the Midwest. These factors may result in bias because of the demographic makeup of
the study cohort and the practice style of the individual surgeon. Second, certain patient-specific factors such as comorbidities may have impacted patient compliance with follow-up,
yet were not analyzed in this study. Third, with patient compliance with the two-year follow-up evaluation of <40% for all
joints combined, this study may lack the statistical power to
identify certain predictors of compliance with postoperative
follow-up visits. Furthermore, a large number of statistical tests
were conducted. As the number of tests increases, the likelihood
increases that any one of these tests is significant but not clinically important. For example, we do not believe that knowledge
of a patient’s body mass index is really of clinical prognostic
importance relative to follow-up compliance. Therefore, caution must be used in evaluating the importance of any individual test. Finally, our comparison group consisted of a subset
of patients willing to participate in a prospective randomized
study, and therefore these patients may have been more likely to
return for follow-up because they were a more motivated patient cohort.
The most important finding from our study is that a
large percentage of our patients did not return for follow-up
beyond the first year after total joint arthroplasty on the basis
of a protocol that was limited to a one-time verbal instruction
from the treating surgeon. Looking at the results from our
comparison group (repeated communications to return for
follow-up), as well as work by Joshi et al.18, a more intensive
surgeon-directed attempt to contact patients can result in a
higher rate of follow-up. Nevertheless, successful follow-up
protocols are expensive and personnel-dependent, and they
may not be covered by insurance carriers.
In an asymptomatic patient, the orthopaedic surgeon’s
primary concern is to detect bearing surface wear and clinically
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silent osteolysis. The peak prevalence of osteolysis-related
problems is at ten years or more after the primary arthroplasty;
therefore, the optimal screening time is in the five to ten-year
interval12,15. Since radiographic screening is the critical evaluation component for these problems, alternative radiographic
surveillance programs carried out at sites convenient for the
patient may provide a more effective screening mechanism to
detect early implant failure.
Appendix
A table showing variables associated with two-year followup compliance of all patients after arthroplasty is available with the electronic versions of this article, on our web site
at jbjs.org (go to the article citation and click on ‘‘Supplementary
Material’’) and on our quarterly CD/DVD (call our subscription
department, at 781-449-9780, to order the CD or DVD). n
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